BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34974809)

  • 1. Long non-coding RNA HOXA11 antisense RNA upregulates spermatogenesis-associated serine-rich 2-like to enhance cisplatin resistance in laryngeal squamous cell carcinoma by suppressing microRNA-518a.
    Shen N; Duan X; Feng Y; Zhang J; Qiao X; Ding W
    Bioengineered; 2022 Jan; 13(1):974-984. PubMed ID: 34974809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
    Li B; Lv Y; Zhang C; Xiang C
    J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
    Song K; Yu P; Zhang C; Yuan Z; Zhang H
    Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H19/miR-107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing autophagy in vitro and in vivo.
    Chen L; Xu Z; Zhao J; Zhai X; Li J; Zhang Y; Zong L; Peng H; Qi J; Kong X; Fang Z; Liu M
    Cell Biol Int; 2021 Mar; 45(3):674-685. PubMed ID: 33314408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma.
    Zhao L; Zheng Y; Zhang L; Su L
    Cancer Biother Radiopharm; 2022 May; 37(4):276-286. PubMed ID: 33571038
    [No Abstract]   [Full Text] [Related]  

  • 8. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
    Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
    Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation-mediated downregulation of the LINC01554 gene accelerates the malignant progression and regulates the chemosensitivity of laryngeal squamous cell carcinoma.
    Wang J; Meng W; Yang J; Cao H; Liu T; Yang C; Yu M; Wang B
    J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 35988928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
    Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.
    Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B
    Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
    Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
    Wan L; Gu D; Jin X
    Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.